Would marijuana legalization save hemp CBD from regulatory overreach?

The federal government is divided no more. That slender Democratic majority could pave the way for Congress to actually vote on legislation that has the support of the Democratic party. And that could change everything.

Todd Runestad, Content Director, NaturalProductsInsider.com

January 13, 2021

4 Min Read
Would marijuana legalization save hemp CBD from regulatory overreach.jpg

Cannabis stocks are flying high after the Democratic wins in Georgia’s two Senate run-off elections on Jan. 5. Tilray is up 60% for the year (that is, since Jan. 1, 2021—so in less than two weeks). Canopy Growth is up 25% in 2021. Aurora Cannabis is up 27%. Cannabis ETF is up 30%. And money talks, right?

Investors are apparently under the belief that a Democratic-controlled U.S. Senate is grounds for full cannabis legalization.

After all, the Secure and Fair Enforcement (SAFE) Act passed the Democratic-led U.S. House of Representatives in September 2019—only to go nowhere in the Republican-led U.S. Senate. And the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019 passed the Democratic-held U.S. House of Representatives in December 2020, only to not being taken up in the GOP-led Senate.

So is it possible that, now that the Democrats control both legislative branches of government in Washington, D.C., including the White House, that the entire cannabis plant could be unshackled from the Controlled Substances Act list?

“I do think it will be a game changer,” said Patrick Goggin, an attorney with the Hoban Law Group, which is representing the Hemp Industries Association in its lawsuits against the Drug Enforcement Agency (DEA) for continued regulatory overreach. “I do think removing marijuana from the schedule would be the beginning of the end of these policies and this campaign.”

Related:Hemp group ‘cautiously optimistic’ about CBD bill in 117th Congress

The policies in question include the regulatory roadblocks that continue to be erected by the big 3 drug warriors, the FDA, USDA and DEA.

The DEA in particular was explicitly written out of any regulatory role around hemp with the 2018 farm bill. But the agency re-insinuated itself with a proposed rule that would make hemp extractors guilty of drug crimes when they go about their business of making hemp extracts, as there includes a brief and transient rise in delta-9 THC levels above the 0.3%THC threshold in the extraction process.

The future of cannabis freedom

Legalizing marijuana entirely holds within it the provocative idea that what distinguishes hemp from marijuana cannabis products is strictly the end-product THC levels—and source would then not matter.

“End product regulation is where this should be,” said Maureen West, in-house counsel for hemp CBD brand Functional Remedies who also was the industrial hemp program manager foer the state of Colorado. “Let’s just regulate the amount of THC in products. It seems to me that’s where this should go.”

With hemp still being held to the definition of 0.3% THC or less, the THC derived from hemp would no longer be a controlled substance. That right there would mean the DEA would, finally, be removed from regulating hemp.

Related:FDA, Congress differ on how CBD should be regulated in supplements

And it would eliminate much of the consternation farmers are feeling around the USDA interim final rule that mandates an unrealistic testing regime.

It still, however, might not mean it’s all clear sailing for hemp.

“Looking at states,” said Rend Al-Mondhiry, attorney at the Amin Talati Wasserman law firm, “if they can regulate, it might not give hemp the relief it needs if state laws are more strict than the federal government provides.”

Could all cannabis be legalized by the 117th Congress, which will conduct business in the U.S. Capitol for the next two years?

In one fell swoop, Congressional hemp legislation—the MORE Act (marijuana legalization), the SAFE Act (financial security for the cannabis industry) chief among them—could be taken care of all at once.

A heavy lift

It’s a heavy lift, to be sure. It would require 60 votes in the Senate if the McConnell rules still abide that require 60 votes for legislation to pass. But only Idaho (and Kansas depending how you look at it) forbids any type of CBD within their borders unless they contain an absolute 0% THC. And all but 13 states have either adult-use or medical marijuana on the books. And cannabis went 5-for-5 in the November elections, including deep-red South Dakota, which passed both medical and recreational marijuana laws in the election. All this movement gives cover for federal elected officials to take the entire country to the promised land.

That’s the title of former President Barack Obama’s book, and also possibly his greatest legacy—starting to unwind the federal prohibition of cannabis when his Justice Department declared in April 2009 that the federal government would not interfere with state cannabis laws.

So where elections have consequences, money also matters. Is the spike in pot stocks a harbinger that federal cannabis legislation could happen? That would strike down much of the regulatory hand-wringing around hemp CBD and liberate the plant—not entirely, as the FDA still has its own rules around claims and pharma preference, but it would surely be one giant leap forward.

About the Author(s)

Todd Runestad

Content Director, NaturalProductsInsider.com, Natural Products Insider

Todd Runestad has been writing on nutrition science news since 1997. He is content director for NaturalProductsInsider.com and Natural Products Insider digital magazines. Other incarnations: supplements editor for NewHope.com, Delicious Living!, and Natural Foods Merchandiser. Former editor-in-chief of Functional Ingredients magazine and still covers raw material innovations and ingredient science.

Connect with me here on LinkedIn.


Todd writes about nutrition science news such as this story on mitochondrial nutrients, innovative ingredients such as this story about 12 trendy new ingredient launches from SupplySide West 2023, and is a judge for the NEXTY awards honoring innovation, integrity and inspiration in natural products including his specialty — dietary supplements. He extensively covered the rise and rise and rise and fall of cannabis hemp CBD. He helps produce in-person events at SupplySide West and SupplySide East trade shows and conferences, including the wildly popular Ingredient Idol game show, as well as Natural Products Expo West and Natural Products Expo East and the NBJ Summit. He was a board member for the Hemp Industries Association.

Education / Past Lives

In previous lives Todd was on the other side of nature from natural products — natural history — as managing editor at the Denver Museum of Nature & Science. He's sojourned to Burning Man and Mount Everest. He graduated many moons ago from the State University of New York College at Oneonta.


"There is not a colds-and-flu season. There is a vitamin D-deficiency season."

"There is no such thing as inclement weather. Only improper attire."

Link answers question, "When taking magnesium, should you also take vitamin D3 2,000 IU?"

"Cannabis is nature's most nearly perfect plant."

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like